Active substance
Results for the substance covid-19 vaccine (ad26.cov2-s [recombinant])
1 result
About this active substance
The COVID-19 vaccine (Ad26.COV2-S [recombinant]) is used to prevent infection with the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. This vaccine uses a non-replicating viral vector based on human adenovirus type 26 (Ad26) genetically modified to express the SARS-CoV-2 spike protein.
The vaccine is administered intramuscularly, usually in a single dose, making it a convenient option for rapid immunization of the population. It is intended for adults, and its efficacy has been demonstrated in preventing severe forms of COVID-19, hospitalizations, and deaths.
Common side effects include pain at the injection site, fever, fatigue, headache, and muscle aches. In very rare cases, thrombotic events associated with thrombocytopenia have been reported.
The COVID-19 vaccine (Ad26.COV2-S [recombinant]) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.
The vaccine is administered intramuscularly, usually in a single dose, making it a convenient option for rapid immunization of the population. It is intended for adults, and its efficacy has been demonstrated in preventing severe forms of COVID-19, hospitalizations, and deaths.
Common side effects include pain at the injection site, fever, fatigue, headache, and muscle aches. In very rare cases, thrombotic events associated with thrombocytopenia have been reported.
The COVID-19 vaccine (Ad26.COV2-S [recombinant]) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.